0.05Open0.05Pre Close0 Volume1 Open Interest435.00Strike Price0.00Turnover38.10%IV6.58%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0126Delta0.0028Gamma8163.60Leverage Ratio-0.0484Theta0.0003Rho103.07Eff Leverage0.0099Vega
Vertex Pharmaceuticals Stock Discussion
nfa
SiteOne’s efforts in non-opioid pain management put it in a unique position relative to Vertex Pharmaceuticals, a major player in the field known for its successful development of cystic fibrosis treatments. Vertex has also been working on non-opioid pain drugs, specifically targeting the NaV1.8 sodium channel, a focal point shared by SiteOne’s lead pro...
At 4:02 p.m. ET, the three indices closed lower. The $Dow Jones Industrial Average (.DJI.US)$ was off 0.70%, losing 300 points. The $S&P 500 Index (.SPX.US)$ was down 1.32% and the $Nasdaq Composite Index (.IXIC.US)$ was off 2.24%.
MACRO
In macro, core retail sales grew by 0.1% month over month, lower than estimated. ...
My name is Kevin Travers and the market is falling today- here is why.
$Alibaba (BABA.US)$ shares declined after a report from the firm Friday morning that it was facing a consumer demand slump, even though its AI cloud business grew 7% to $4.2B in its second fiscal quarter.
$Applied Materials (AMAT.US)$ fell 8% after r...
📊⚡️📊
yahoo.com/news/...
$Vertex Pharmaceuticals (VRTX.US)$. $Citigroup (C.US)$
No comment yet